Skip to content

UK Series B raises in 2018

Focus: Medical
Founded: 2015
Number of Funding Rounds: 3
Last Funding Date: 20/06/2018
Last Funding Amount: $116,000,000
Total Funding: $156,000,000

Freeline Therapeutics is a biopharmaceutical company specialising in developing liver-directed gene therapies for bleeding disorders.

Interested in learning more about fast-growing startups?

This website uses cookies. For more information about these please click here.
By continuing to browse you consent to the use of cookies

We use technology such as cookies on our site to personalise content, provide social media features such as sharing and analyse our traffic using Google Analytics.

Click below to consent to the use of this technology during your visit.

Find out more

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.